If you're having trouble viewing this email, you can read it online.

 
Monday, October 6, 2008
 
 
•  IVIG Supply Index •  Open Market Pricing  
•  Albumin Supply Index •  Subscribe to IG Living  
•  In the News •  MyFluVaccine Orders  
•  FFF News •  Current Reimbursement Rates  
 
 
 
FDA Approves New Indication for Gamunex®
 
 


IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for all our customers who have established product allocations with us (not individual or group allocations). Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.

 

Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have established product allocations with us (not individual or group allocations). Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
 

From Science Daily
CDC Urges More Children to Get Flu Shots

From Reuters
Obstetricians Urge Pregnant Women to Get Flu Shots

From Baxter
Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease

From Dallas Morning News
What Are Shingles, and Why Are More People Getting Them?

From PR Newswire
Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder

From CSL Behring
Data Published in Journal of Clinical Immunology Show Privigen™ Demonstrates Effectiveness and Tolerability in Patients with Primary Immunodeficiencies

From the Washington Post
Gardasil Approved for Additional Uses

 

The FDA has recently approved Talecris Biotherapeutics’ Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder affecting approximately 25,000 people in the United States. CIDP is characterized by progressive muscle weakness and impaired sensory function in the arms and legs.

The only therapy of any kind with an approved indication for the treatment of CIDP, Gamunex now has the broadest set of FDA-approved indications of any liquid immune globulin intravenous (IVIG) therapy.

Talecris is developing programs to educate neurologists on the CIDP indication and the clinical trial that proved its efficacy. The company also reports working to substantially increase supplies of Gamunex in 2009.

Gamunex is available from FFF, where our Wow! Customer Care Team is always ready to assist you at (800) 843-7477.

 
      
 
 
  Albumin All Sizes Varies  
 
 
 
 
  Carimune NF All Sizes $64.70/gm  
  Flebogamma All Sizes $77.30/gm  
  Gammagard Liquid All Sizes $77.30/gm  
  Gammagard S/D All Sizes $75.50/gm  
  Gamunex All Sizes $77.30/gm  
  Octagam All Sizes $77.30/gm  
  Privigen All Sizes $77.30/gm  
 
 
 
 
  All Hyperimmunes All Sizes Varies  
 
 
 

FFF Offers Free Influenza Vaccine Reference Charts

We are pleased to provide another tool to help make your job easier: the 2008-2009 Injectable Influenza Vaccine Reference Chart. This handy reference chart lists all injectable influenza vaccines and the CDC Dosing Chart and Guidelines.

Like our other complimentary reference charts, including the immune globulin, hyperimmune globulin and factor charts, the new influenza chart can be hung on the wall for quick reference or it can be folded neatly for file storage. All our charts contain useful manufacturer product information and serve as guides in the pharmacy, clinic or physician office.

To order the new influenza chart or any of FFF's other product reference charts, please visit our website.

 
 
- Hyperimmune
- Immune Globulin
- Factor
- Injectable Influenza
 
 
Reimbursement Rates
Carimune injection:
  $58.472/gm
Flebogamma injection:
  $71.398/gm
Gammagard liquid injection:
  $70.012/gm
Gammagard S/D :
  $58.472/gm
Gamunex injection:
  $69.596/gm
Octagam injection:
  $71.726/gm
Privigen injection:
  $67.272/gm
  Effective through
December 31, 2008
 
 
Manufacturer/Product
Apotex
  - HepaGam B
Baxter
  - WinRho SDF liquid
CSL Behring
 

- CytoGam
- Rhophylac

Genzyme
  - Thymoglobulin
Massachusetts
Public Health Biologic
Laboratories
  - BabyBIG
sanofi pasteur
  - Imogam Rabies-HT
Talecris
  - HyperHEP B S/D
- HyperRAB S/D
- HyperRHO S/D
- HyperTET S/D
 
 
 
 
 

BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. CIick here to contact FFF Enterprises or call 800-843-7477.

This email was sent to: %%emailaddr%%
Unsubscribe
Update Profile
I want to report technical trouble with BioSupply Trends

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%